| Deciphering the oncogenic potential of ADAM9 in hepatocellular carcinoma through bioinformatics and experimental approaches. | Deciphering the oncogenic potential of ADAM9 in hepatocellular carcinoma through bioinformatics and experimental approaches.
Jiang L, Huang W, Cao M, Jiang Y, Li S, Li M, Yang R, Wu Z, Wang Y, Lv C, Huang Z., Free PMC Article | 11/7/2024 |
| ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection. | ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection.
Bazzone LE, Zhu J, King M, Liu G, Guo Z, MacKay CR, Kyawe PP, Qaisar N, Rojas-Quintero J, Owen CA, Brass AL, McDougall W, Baer CE, Cashman T, Trivedi CM, Gack MU, Finberg RW, Kurt-Jones EA., Free PMC Article | 08/13/2024 |
| LncRNA NEAT1 targets miR-125/ADAM9 mediated NF-kappaB pathway in inflammatory response of rosacea. | LncRNA NEAT1 targets miR-125/ADAM9 mediated NF-κB pathway in inflammatory response of rosacea.
Xu S, Dong W., Free PMC Article | 08/1/2024 |
| ADAM9 deubiquitination induced by USP22 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition of trophoblast cells in preeclampsia. | ADAM9 deubiquitination induced by USP22 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition of trophoblast cells in preeclampsia.
Liu J, Wang Y, Zhang S, Sun L, Shi Y. | 02/6/2024 |
| The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis. | The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis.
Chang AC, Lin LW, Chen YC, Chen PC, Liu SC, Tai HC, Wu HC, Sung SY, Lin TH, Tang CH., Free PMC Article | 02/14/2023 |
| Knockdown of circ-ADAM9 inhibits malignant phenotype and enhances radiosensitivity in breast cancer cells via acting as a sponge for miR-383-5p. | Knockdown of circ-ADAM9 inhibits malignant phenotype and enhances radiosensitivity in breast cancer cells via acting as a sponge for miR-383-5p.
Song P, Wu J, Chen J, Wang F, Chen J, Wang G. | 01/28/2023 |
| ADAM9: A regulator between HCMV infection and function of smooth muscle cells. | ADAM9: A regulator between HCMV infection and function of smooth muscle cells.
He H, Tan Y, Tang Z, Wang L, Liu S, Wu G. | 01/21/2023 |
| IL-17A Promotes Epithelial ADAM9 Expression in Cigarette Smoke-Related COPD. | IL-17A Promotes Epithelial ADAM9 Expression in Cigarette Smoke-Related COPD.
Li D, Wang T, Ma Q, Zhou L, Le Y, Rao Y, Jin L, Pei Y, Cheng Y, Huang C, Gai X, Sun Y., Free PMC Article | 10/29/2022 |
| Circ_0005714/miR-223-3p/ADAM9 regulatory axis affects proliferation, migration, invasion, and angiopoiesis in trophoblast cells. | Circ_0005714/miR-223-3p/ADAM9 regulatory axis affects proliferation, migration, invasion, and angiopoiesis in trophoblast cells.
Hu X, Xia W. | 10/22/2022 |
| Metalloprotease ADAM9 cleaves ephrin-B ligands and differentially regulates Wnt and mTOR signaling downstream of Akt kinase in colorectal cancer cells. | Metalloprotease ADAM9 cleaves ephrin-B ligands and differentially regulates Wnt and mTOR signaling downstream of Akt kinase in colorectal cancer cells.
Chandrasekera P, Perfetto M, Lu C, Zhuo M, Bahudhanapati H, Li J, Chen WC, Kulkarni P, Christian L, Liu J, Yien YY, Yu C, Wei S., Free PMC Article | 09/17/2022 |
| Relevance of A Disintegrin and Metalloproteinase Domain-Containing (ADAM)9 Protein Expression to Bladder Cancer Malignancy. | Relevance of A Disintegrin and Metalloproteinase Domain-Containing (ADAM)9 Protein Expression to Bladder Cancer Malignancy.
Moriwaki M, Le TT, Sung SY, Jotatsu Y, Yang Y, Hirata Y, Ishii A, Chiang YT, Chen KC, Shigemura K, Fujisawa M., Free PMC Article | 07/2/2022 |
| Cancer-associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of ADAM9. | Cancer-associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of ADAM9.
Ao T, Mochizuki S, Kajiwara Y, Yonemura K, Shiraishi T, Nagata K, Shinto E, Okamoto K, Nearchou IP, Shimazaki H, Kishi Y, Okada Y, Ueno H. | 05/7/2022 |
| Ubiquitin-specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation. | Ubiquitin-specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation.
Xiao Y, Ma W, Hu W, Di Q, Zhao X, Ma X, Chen X, Sun P, Wu H, Wu Z, Chen W., Free PMC Article | 04/2/2022 |
| High Glucose Impairs Expression and Activation of MerTK in ARPE-19 Cells. | High Glucose Impairs Expression and Activation of MerTK in ARPE-19 Cells.
Puddu A, Ravera S, Panfoli I, Bertola N, Maggi D., Free PMC Article | 03/12/2022 |
| ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma. | ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma.
Lin YS, Kuo TT, Lo CC, Cheng WC, Chang WC, Tseng GC, Bai ST, Huang YK, Hsieh CY, Hsu HS, Jiang YF, Lin CY, Lai LC, Li XG, Sher YP., Free PMC Article | 02/19/2022 |
| Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort. | Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.
Carapito R, Li R, Helms J, Carapito C, Gujja S, Rolli V, Guimaraes R, Malagon-Lopez J, Spinnhirny P, Lederle A, Mohseninia R, Hirschler A, Muller L, Bastard P, Gervais A, Zhang Q, Danion F, Ruch Y, Schenck M, Collange O, Chamaraux-Tran TN, Molitor A, Pichot A, Bernard A, Tahar O, Bibi-Triki S, Wu H, Paul N, Mayeur S, Larnicol A, Laumond G, Frappier J, Schmidt S, Hanauer A, Macquin C, Stemmelen T, Simons M, Mariette X, Hermine O, Fafi-Kremer S, Goichot B, Drenou B, Kuteifan K, Pottecher J, Mertes PM, Kailasan S, Aman MJ, Pin E, Nilsson P, Thomas A, Viari A, Sanlaville D, Schneider F, Sibilia J, Tharaux PL, Casanova JL, Hansmann Y, Lidar D, Radosavljevic M, Gulcher JR, Meziani F, Moog C, Chittenden TW, Bahram S. | 01/29/2022 |
| Long non-coding RNA ASMTL-AS1 deteriorates the oncogenicity of osteosarcoma by decoying microRNA-342-3p and consequently raising ADAM9 expression. | Long non-coding RNA ASMTL-AS1 deteriorates the oncogenicity of osteosarcoma by decoying microRNA-342-3p and consequently raising ADAM9 expression.
Hou C, Sun F, Sun M. | 01/1/2022 |
| Overexpression of ADAM9 decreases radiosensitivity of hepatocellular carcinoma cell by activating autophagy. | Overexpression of ADAM9 decreases radiosensitivity of hepatocellular carcinoma cell by activating autophagy.
Zhu L, Zhao Y, Yu L, He X, Wang Y, Jiang P, Yu R, Li W, Dong B, Wang X, Dong Y., Free PMC Article | 01/1/2022 |
| ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-beta1. | ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-β1.
Umeda M, Yoshida N, Hisada R, Burbano C, Orite SYK, Kono M, Kyttaris VC, Krishfield S, Owen CA, Tsokos GC., Free PMC Article | 12/4/2021 |
| Analysis of ADAM9 regulation and function in vestibular schwannoma primary cells. | Analysis of ADAM9 regulation and function in vestibular schwannoma primary cells.
Nattmann A, Breun M, Monoranu CM, Matthies C, Ernestus RI, Löhr M, Hagemann C., Free PMC Article | 08/21/2021 |
| Involvement of the A disintegrin and metalloproteinase 9 in oral cancer cell invasion. | Involvement of the A disintegrin and metalloproteinase 9 in oral cancer cell invasion.
Buranaphatthana W, Wu S, Makeudom A, Sastraruji T, Supanchart C, Krisanaprakornkit S. | 07/17/2021 |
| Long non-coding RNA (lncRNA) HOXB-AS3 promotes cell proliferation and inhibits apoptosis by regulating ADAM9 expression through targeting miR-498-5p in endometrial carcinoma. | Long non-coding RNA (lncRNA) HOXB-AS3 promotes cell proliferation and inhibits apoptosis by regulating ADAM9 expression through targeting miR-498-5p in endometrial carcinoma.
Xing Y, Sun X, Li F, Jiang X, Jiang A, Li X, Lv R, Shao L., Free PMC Article | 07/3/2021 |
| The emerging role of the MiR-1272-ADAM9-CDCP1 signaling pathway in the progression of glioma. | The emerging role of the MiR-1272-ADAM9-CDCP1 signaling pathway in the progression of glioma.
Geng F, Lu GF, Luo YJ, Dominguez S, Kong DY, Shen LH, Luo XM, Yang X, Hu M, Lai WS, Jiang ZS, Chen YS., Free PMC Article | 05/15/2021 |
| An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases. | An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases.
Chou CW, Huang YK, Kuo TT, Liu JP, Sher YP., Free PMC Article | 04/17/2021 |
| Role of ADAM9 and miR-126 in the development of abdominal aortic aneurysm. | Role of ADAM9 and miR-126 in the development of abdominal aortic aneurysm.
Shen G, Sun Q, Yao Y, Li S, Liu G, Yuan C, Li H, Xu Y, Wang H. | 04/13/2021 |